ClinicalTrials.gg
Sign In

Malabsorption Syndromes clinical trials

The registry lists 54 studies for Malabsorption Syndromes across more than 10 countries. 12 are recruiting or about to start. 14 of them are mainly about Malabsorption Syndromes (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-29. Counting its 6 narrower conditions too, such as Celiac Disease: 666 studies, 126 open.

Get an email when these change. Save the Malabsorption Syndromes studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
33
Recruiting
8
Status unknown
5
Not yet recruiting
2
Active, not recruiting
2
Enrolling by invitation
2

Phase

Phase 3
8
Phase 2
7
Phase 1
3
Phase 4
2

Where

United States
21
United Kingdom
9
Germany
6
Italy
5
Israel
5
France
4

Who runs them

Boston Children's Hospital (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Elgan Pharma Ltd. (3) · University of Kansas Medical Center (2) · Hvidovre University Hospital (2) · ImmusanT, Inc. (2) · Dr. Schär AG / SPA (2) · Zealand Pharma (2)

What is being tested here

Drugs under test in Malabsorption Syndromes studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Glepaglutide122
Glutens101
Nexvax2002
Amino Acids001
Ustekinumab001
SMOFlipid001
Apilimod001
Human Growth Hormone001
Colesevelam001
Lidocaine011

Coming up

3phase 3 studies under way
6studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 8 Malabsorption Syndromes studies recruiting now, 4 (50%) set no upper age limit and 3 (38%) stop at 75 or younger. 5 (63%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
103 (38%)3 (38%)
186 (75%)6 (75%)
305 (63%)5 (63%)
405 (63%)5 (63%)
505 (63%)5 (63%)
655 (63%)5 (63%)
755 (63%)5 (63%)
855 (63%)5 (63%)

Across all 54 studies, recruiting or not: 52% stop at 75 or younger and 35% at 65; 37% take children; 0% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Malabsorption Syndromes studies take

Of 16 interventional studies with no phase under Malabsorption Syndromes, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo12–65 · 16 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 → or search them.